Lin Shi

2.1k total citations · 1 hit paper
61 papers, 1.6k citations indexed

About

Lin Shi is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Lin Shi has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 13 papers in Biomedical Engineering and 11 papers in Materials Chemistry. Recurrent topics in Lin Shi's work include Advanced biosensing and bioanalysis techniques (18 papers), RNA Interference and Gene Delivery (12 papers) and Advanced Nanomaterials in Catalysis (8 papers). Lin Shi is often cited by papers focused on Advanced biosensing and bioanalysis techniques (18 papers), RNA Interference and Gene Delivery (12 papers) and Advanced Nanomaterials in Catalysis (8 papers). Lin Shi collaborates with scholars based in China, United States and Japan. Lin Shi's co-authors include Tao Li, Yudie Sun, Lan Mi, Zhilin Zhang, Huan Zhang, Dong Tang, Daorong Wang, Tian Chen, Yong Yang and Qiwei Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and PLoS ONE.

In The Last Decade

Lin Shi

59 papers receiving 1.5k citations

Hit Papers

Regulatory role of short-chain fatty acids in inflammator... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Shi China 21 964 422 271 232 140 61 1.6k
Hae Yun Nam South Korea 22 1.1k 1.1× 497 1.2× 271 1.0× 212 0.9× 206 1.5× 32 2.2k
Roghayeh Sheervalilou Iran 23 785 0.8× 338 0.8× 149 0.5× 350 1.5× 111 0.8× 80 1.7k
Li Zou China 24 1.1k 1.2× 438 1.0× 328 1.2× 342 1.5× 80 0.6× 82 1.8k
Wenjuan Ma China 26 1.0k 1.1× 454 1.1× 381 1.4× 200 0.9× 111 0.8× 53 1.9k
Qiusha Tang China 20 925 1.0× 661 1.6× 292 1.1× 400 1.7× 109 0.8× 44 1.7k
Yi‐Jang Lee Taiwan 26 840 0.9× 340 0.8× 165 0.6× 306 1.3× 298 2.1× 73 1.6k
Ronggui Hu China 22 1.1k 1.1× 370 0.9× 314 1.2× 222 1.0× 255 1.8× 56 2.0k
Nina Filipczak United States 23 1.0k 1.1× 720 1.7× 243 0.9× 155 0.7× 188 1.3× 44 2.2k
Boyun Kim South Korea 24 669 0.7× 225 0.5× 232 0.9× 376 1.6× 216 1.5× 74 1.7k
Houría Boulaiz Spain 28 928 1.0× 406 1.0× 220 0.8× 219 0.9× 332 2.4× 84 2.0k

Countries citing papers authored by Lin Shi

Since Specialization
Citations

This map shows the geographic impact of Lin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shi more than expected).

Fields of papers citing papers by Lin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shi. The network helps show where Lin Shi may publish in the future.

Co-authorship network of co-authors of Lin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Shi. A scholar is included among the top collaborators of Lin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Shi. Lin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Junhao, Guoxi Li, Lin Shi, et al.. (2025). The m6A RNA demethylase FTO promotes radioresistance and stemness maintenance of glioma stem cells. Cellular Signalling. 132. 111782–111782. 2 indexed citations
2.
Yang, Wensheng, Qing Liu, Li Yang, et al.. (2025). Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease. Acta Pharmacologica Sinica. 46(7). 1958–1973.
3.
Liu, Jia, Lin Shi, Xiaohuan Lu, et al.. (2024). Ultrasmall ruthenium nanozyme with RONS scavenging and anti-inflammatory effects for effective prevention of postoperative peritoneal adhesion. Chemical Engineering Journal. 485. 150001–150001. 10 indexed citations
4.
Liu, Yueyue, Chao Guo, Bin Liu, et al.. (2024). Nondigestible stachyose binds membranous HSP90β on small intestinal epithelium to regulate the exosomal miRNAs: A new function and mechanism. Cell Metabolism. 37(2). 345–360.e6. 7 indexed citations
6.
Zhang, Zhilin, Lin Shi, Keyan Wu, et al.. (2022). Apigenin regulates the migration, invasion, and autophagy of hepatocellular carcinoma cells by downregulating YAP. Neoplasma. 69(2). 292–302. 9 indexed citations
7.
Zheng, Jiao, Qiwei Wang, Lin Shi, Lili Shi, & Tao Li. (2022). Calcium-Differentiated Cellular Internalization of Allosteric Framework Nucleic Acids for Targeted Payload Delivery. Analytical Chemistry. 94(25). 9097–9105. 3 indexed citations
8.
Chen, Junfa, Jing Jin, Kaiqiang Li, et al.. (2022). Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke. Frontiers in Cellular Neuroscience. 16. 868323–868323. 20 indexed citations
9.
Shi, Lin, et al.. (2021). CircSEC24A promotes IL‐1β‐induced apoptosis and inflammation in chondrocytes by regulating miR‐142‐5p/SOX5 axis. Biotechnology and Applied Biochemistry. 69(2). 701–713. 17 indexed citations
10.
Liu, Xuejiao, Lin Shi, Guanzheng Liu, et al.. (2020). MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation. Journal of Cellular and Molecular Medicine. 24(13). 7550–7562. 24 indexed citations
11.
Shi, Lin, Huize Liu, Yifeng Wang, et al.. (2019). SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s. Cancer Cell International. 19(1). 305–305. 6 indexed citations
12.
Shi, Lin, et al.. (2018). The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and migration in VSMCs of hypertension. Biochemical and Biophysical Research Communications. 501(3). 688–695. 82 indexed citations
13.
14.
Wang, Feng, Lijun Yang, Jianping Sun, et al.. (2017). Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2. Molecular BioSystems. 13(7). 1345–1354. 12 indexed citations
15.
Zhang, Xuehong, Zhiwei Zhou, Hua Bai, et al.. (2017). The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo. BioFactors. 43(6). 812–820. 18 indexed citations
16.
Wang, Zhiqiang, et al.. (2016). Molecular cloning and pharmacological characterization of giant panda (Ailuropoda melanoleuca) melanocortin-4 receptor. General and Comparative Endocrinology. 229. 32–40. 7 indexed citations
17.
Shi, Lin, Kai Wang, & Yong Yang. (2016). Adhesion-based tumor cell capture using nanotopography. Colloids and Surfaces B Biointerfaces. 147. 291–299. 20 indexed citations
18.
Wang, Feng, Na Cui, Lijun Yang, et al.. (2015). Resveratrol Rescues the Impairments of Hippocampal Neurons Stimulated by Microglial Over-Activation In Vitro. Cellular and Molecular Neurobiology. 35(7). 1003–1015. 19 indexed citations
19.
Huang, Jie, et al.. (2015). Pharmacologic analyses of four chicken melanocortin-4 receptor mutations. Domestic Animal Endocrinology. 54. 68–75. 7 indexed citations
20.
Shi, Lin. (1988). Main saponins of notoginseng and ginseng ginsenosides decrease the contents of tissue lipofuscin and serum lipid peroxides in the old rats. Zhongguo yaolixue yu dulixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026